• Alembic Pharma raises Rs 150 crore via NCDs expressbpd
    March 20, 2019
    Drug firm Alembic Pharmaceuticals has said it has raised Rs 150 crore through the allotment of non-convertible debentures (NCDs) on private placement basis. These NCDs carry a coupon rate of 8.37 per cent per annum and are proposed to be listed on NSE.
PharmaSources Customer Service